Lewis A Chodosh

8PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 10, 2025
Residual Breast Cancer Cells Co-opt SOX5-Driven Endochondral Ossification to Maintain Dormancy.

Amulya Sreekumar, Eric Blankemeyer, Christopher J Sterner

|Sep 02, 2025
Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial.

Angela DeMichele, Amy S Clark, Emily Shea

|Jul 14, 2025
Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain Dormancy.

Amulya Sreekumar, Eric Blankemeyer, Christopher J Sterner

|Jan 19, 2022
Aberrant RET expression affects normal mammary gland post-lactation transition, enhancing cancer potential.

Sabrina A Vallone, Martín García Solá, Carolina Schere-Levy

Pageof 2